
Daxxify (daxibotulinumtoxinA-lanm) is a relatively new injectable neurotoxin from Revance Therapeutics that is used to reduce the appearance of facial wrinkles, particularly frown lines (glabellar lines) between the eyebrows. Like other neurotoxins (such as Botox, Dysport, and Jeuveau), Daxxify contains botulinum toxin type A, but it is formulated to offer longer-lasting results.
Benefits of Daxxify
- Extended Duration of Results: One of Daxxify’s primary benefits is its longevity. Clinical trials have shown that the effects of Daxxify can last up to 6 months, and sometimes up to 9 months in some individuals. This is significantly longer than other neurotoxins, which typically last about 3 to 4 months.
- Wrinkle Reduction: Daxxify is effective in reducing the appearance of moderate to severe glabellar lines, providing a smoother, more youthful look to the skin.
- Reduced Treatment Frequency: Due to its longer duration, patients can enjoy fewer treatments per year to maintain results, which can be convenient for those with busy schedules or those looking to reduce the frequency of injectables.
- Peptide-Enhanced Formula: Daxxify is unique in that it uses a peptide-based stabilization system instead of animal or human-derived proteins. This innovative formulation may contribute to the longer duration and appeal to patients looking for vegan-friendly options in cosmetic treatments.
- Consistent Results: Many patients report consistent and reliable outcomes with Daxxify, allowing for predictable and smooth results when reducing wrinkles and fine lines.
- Non-Surgical with Minimal Downtime: Like other injectables, Daxxify is minimally invasive, making it a good option for patients who want cosmetic improvements without the need for surgery or extended recovery time.

How Daxxify Differs from Other Neurotoxins
Daxxify’s longer-lasting effects are its standout feature, setting it apart from other neurotoxins. The peptide-based technology in Daxxify is also a novel addition, as most other neurotoxins use stabilizers derived from human or animal products. This technology may give Daxxify an edge for patients who prefer more extended intervals between treatments, as well as those interested in innovative, protein-free cosmetic options.


